FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080741 [Registered on: 18/02/2025] Trial Registered Prospectively
Last Modified On: 06/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Homoeopathic treatment of neck pain in adults 
Scientific Title of Study   Efficacy of Individualized Homoeopathic Medicines in Q-potency in Treatment of Cervical spondylosis: A Double-blind, Randomized, Placebo-controlled, Trial.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
U1111-1318-3841  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SHABNAM REYAZ 
Designation  Postgraduate Trainee 
Affiliation  THE CALCUTTA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL 
Address  Department Practice Of Medicine, Room No-17 and 21 265-266 Acharya Prafulla Chandra Road

Kolkata
WEST BENGAL
700009
India 
Phone  8276857991  
Fax    
Email  reyaz.shabnam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr HIMANGSU HAIT 
Designation  PhD(Homoeopathy), MD (Homoeopathy), PROFESSOR,HOD, PRACTICE OF MEDICINE. 
Affiliation  THE CALCUTTA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL 
Address  THE CALCUTTA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL, 265-266, Acharya Prafulla Chandra Road

Kolkata
WEST BENGAL
700009
India 
Phone  9433565680  
Fax    
Email  haitdrhimangsu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr SHABNAM REYAZ 
Designation  Postgraduate Trainee 
Affiliation  THE CALCUTTA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL 
Address  Department Practice Of Medicine, Room No-17 and 21 265-266 Acharya Prafulla Chandra Road

Kolkata
WEST BENGAL
700009
India 
Phone  8276857991  
Fax    
Email  reyaz.shabnam@gmail.com  
 
Source of Monetary or Material Support  
The Calcutta Homoeopathic Medical College and Hospital 265-266, Acharya Prafulla Chandra Road, Kolkata 700009 
 
Primary Sponsor  
Name  The Calcutta Homoeopathic Medical College and Hospital 
Address  265-266, Acharya Prafulla Chandra Road, Kolkata 700009 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SHABNAM REYAZ  The Calcutta Homoeopathic Medical College and Hospital  Department Practice Of Medicine OPD no 17 and 21, 265-266, Acharya Prafulla Chandra Road, Kolkata 700009
Kolkata
WEST BENGAL 
8276857991

reyaz.shabnam@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M478||Other spondylosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Identical-looking placebo with concomitant care  This arm will receive placebo, indistinguishable in appearance from verum. Each dose of placebo shall consist of one non-medicated globule no.10 is to be dissolved in 100 ml of dist. Water with addition of some rectified spirit and mixed well to make 7 doses regularly or as required then the vial is succussed and after that one table spoon (15 ml) of the medicinal solution is taken and put in a glass of water of about 120ml (8table spoonful). This is stirred thoroughly and from it a dose-5ml (1 tea spoonful) is given to the patient, to be taken orally in empty stomach dose and repeated depending upon the individual requirement of the case. Patients will be advised to refrain from taking tea, coffee, alcoholic beverages like whisky, brandy etc, and foods possessing medicinal qualities like onion, pepper, cloves, cinnamon, ginger and bitter substance, and old rancid foods etc. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of therapy: 3months.  
Intervention  Individualized homoeopathic medicines in Q potency with concomitant care  Intervention is planned as administering indicated homoeopathic medicines in Q potency, as decided appropriate to the case or condition. In Q potency scale one medicated globule no.10 of the indicated remedy is dissolved in 100 ml of dist. Water with addition of some rectified spirit and mixed well to make 7 doses regularly or as required then the vial is succussed and after that one table spoon (15 ml) of the medicinal solution is taken and put in a glass of water of about 120ml (8table spoonful). This is stirred thoroughly and from it a dose-5ml (1 tea spoonful) is given to the patient, to be taken orally in empty stomach dose and repeated depending upon the individual requirement of the case. Patients will be advised to refrain from taking tea, coffee, alcoholic beverages like whisky, brandy etc, and foods possessing medicinal qualities like onion, pepper, cloves, cinnamon, ginger and bitter substance, and old rancid foods etc. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of therapy: 3months.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients with age group between 18 to 65 years.
2. Patients with clinical findings and radiological findings for cervical spondylosis.
3. Patients of both sexes.
4. Patients willing to give consent to take homoeopathic treatment.
5. Patients with mild to moderate degenerative radiological changes.
6. Patients not having any major disorder associated with cervical spondylosis.
7. Literate patients; able to read English or Bengali, Hindi
 
 
ExclusionCriteria 
Details  1. Patients having major life-threatening disorder associated with cervical spondylosis
2. Pregnant and puerperal women, and lactating mothers.
3. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life.
4. Other non-specific neck pain lesion, acute neck strain, or whiplash injury.
5. Patient under other medication for the same complaint especially for 6 weeks.
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
Numerical Rating Scale (NRS)   At baseline, every 4 weeks, upto three months 
 
Secondary Outcome  
Outcome  TimePoints 
Neck Disability Index (NDI) questionnaire  At baseline, every 4 weeks, upto three months 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Cervical Spondylosis is a wide spread medical condition that significantly impacts patients quality of life. Cervical spondylosis is a degenerative disease that typically develops as a consequence of ligament and facet joint disorders. Its common symptoms include neck pain, numbness in the root innervation area, nausea, vomiting, vertigo and other related symptoms. In the general population the patients prevalence of neck pain ranges from 0.4 % to 41.5 %, the 1 year incidence ranges from 4.8% to 79.5% and lifetime prevalence may be as high as 86.8%. Age is the most common risk factor for cervical spondylosis. The condition is very common in patients who are middle aged and older. Conservative treatment with analgesics only provides temporary relief. Non-steroidal anti-inflammatory medication used to treat pain and inflammation have limitation since unpleasant side effects occur frequently. Where as in Homoeopathic treatment with individualized medicines, the effectiveness of  the treatment with regards to improving the daily life activities in patients suffering from cervical spondylosis is higher. Our aimed to evaluate effects of Homoeopathic medicines beyond placebo by conducting 3- month Double-Blind, Randomized (2:1) , Placebo-controlled Trial of individualized Homoeopathic Medicines i Q potency against placebo at The Calcutta Homoeopathic Medical College and Hospital on 140 participants with Cervical Spondylosis symptoms. For Primary outcome assessment Numerical Rating Scale (NRS) scale is administered and for secondary outcome Neck disability Index Questionairre is taken.  
Close